Therefore, downregulated expression of LAMP2, ATG9A, and CISD2 in SHIV-Exo and LC3B-II in HBMVECs treated with HIV+ Patient-Exo may be linked to HAND. Here, ATG9A is linked to HIV-associated neurocognitive disorder.